Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Autor: Zawadi, Mohamed-Ayman, Volet, Julien, Cavaglione, Gérard, Lepere, Céline, Rougier, Philippe, Zaanan, Aziz, Besson, Dominique, Fawzi, Kara Slimane, Adenis, Antoine, Gatineau-Sailliant, Gilles, Brezault, Catherine, Coriat, Romain, Tougeron, David, Hautefeuille, Vincent, Chone, Laurence, Molin, Yann, Seitz, Jean-François, Le Tallec, Véronique Jestin, Ben Abdelghani, Meher, Villing, Anne-Laure, Aouakli, Amar, Sebbagh, Virginie, Bedjaoui, Ahmed, Mitry, Emmanuel, Carola, Elisabeth, Boulat, Olivier, Queuniet, Anne-Marie, Capitain, Olivier, Jouve, Jean-Louis, Baumgaertner, Isabelle, Almaric, Françoise, Bonnetain, Franck, Subtil, Fabien, Aparicio, T., Bouché, O., Francois, E., Retornaz, F., Barbier, E., Taieb, J., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Bedenne, L., Paillaud, E.

Publikováno v: In European Journal of Cancer July 2018 97:16-24

Recent insights in the therapeutic management of patients with gastric cancer

Autor: de Mestier, Louis, Lardière-Deguelte, Sophie, Volet, Julien, Kianmanesh, Reza, Bouché, Olivier

Publikováno v: In Digestive and Liver Disease September 2016 48(9):984-994

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Autor: Conroy, Thierry, Hammel, Pascal, Hebbar, Mohamed, Ben Abdelghani, Meher, Wei, Alice, Raoul, Jean-Luc, Choné, Laurence, Francois, Eric, Artru, Pascal, Biagi, James, Lecomte, Thierry, Assenat, Eric, Faroux, Roger, Ychou, Marc, Volet, Julien, Sauvanet, Alain, Breysacher, Gilles, Di Fiore, Frédéric, Cripps, Christine, Kavan, Petr, Texereau, Patrick, Bouhier-Leporrier, Karine, Khemissa-Akouz, Faiza, Legoux, Jean-Louis, Juzyna, Beata, Gourgou, Sophie, O'Callaghan, Christopher, Jouffroy-Zeller, Claire, Rat, Patrick, Malka, David, Castan, Florence, Bachet, Jean-Baptiste, Trials Group, Canadian Cancer, Group, Unicancer-GI–PRODIGE

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (25), pp.2395-2406. ⟨10.1056/NEJMoa1809775⟩

International audience; BACKGROUND:Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy. We compar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef30724c50e78ea4d2ef31b2e28651f
https://hal.umontpellier.fr/hal-02281628

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.